Bromfield Sneider Wealth Advisors’s Amgen AMGN Stock Holding History

Bromfield Sneider Wealth Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$41.2K	Hold	145	–	–	0.03%	76
2023 Q4	$41.8K	Hold	145	–	–	0.03%	74
2023 Q3	$39K	Hold	145	–	–	0.03%	73
2023 Q2	$32.2K	Hold	145	–	–	0.03%	82
2023 Q1	$35.1K	Hold	145	–	–	0.03%	78
2022 Q4	$38.1K	Hold	145	–	–	0.04%	72
2022 Q3	$33K	Hold	145	–	–	0.04%	69
2022 Q2	$35K	Hold	145	–	–	0.04%	70
2022 Q1	$35K	Buy	+145	New	+$33.3K	0.04%	79

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bromfield Sneider Wealth Advisors's AMGN Position: Q1 2024 in Review

Bromfield Sneider Wealth Advisors held its Amgen (AMGN) position steady in Q1 2024 at 145 shares worth $41.2K. The position accounts for 0.03% of the portfolio, ranked #76.

Bromfield Sneider Wealth Advisors first reported a position in AMGN in Q1 2022 and has held it in 9 quarters since. The position peaked at $41.8K in Q4 2023. 2,721 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

Bromfield Sneider Wealth Advisors held 145 shares of Amgen worth $41.2K as of Q1 2024.
Bromfield Sneider Wealth Advisors left its Amgen share count unchanged in Q1 2024.
Amgen made up 0.03% of Bromfield Sneider Wealth Advisors's portfolio in Q1 2024, its #76 holding.
Bromfield Sneider Wealth Advisors first reported a position in Amgen in Q1 2022 and has held it in 9 quarters since.
Bromfield Sneider Wealth Advisors's Amgen position peaked at $41.8K in Q4 2023.
2,721 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Bromfield Sneider Wealth Advisors's 13F filing for Q1 2024, filed 10 Apr 2024.